Founded in 2015, Emedgene has built an AI-based platform to automatically surface insights from genomics data. Previously, this data would need to be analyzed by genomics experts, of which there are only a few thousand around the world. Emedgene applies machine learning algorithms to generate these insights on the fly, essentially teaching computers how to be genetic researchers.
The company was built as a part of the Microsoft Accelerator and initially chose Azure as its cloud provider. They’ve since migrated to AWS to both take advantage of cost savings and advanced machine learning tools. Watch the above video to hear from Niv Mizrahi, co-founder and CTO of Emedgene, and learn why he chose to move to AWS and how it’s been since.